Physician profile
Bridget Pitcock
NPI 1083200182
$1,151.80
in general payments reported to CMS, 2019-2025
10 companies · $526 in 2025
The $526 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $542 · 2022: $83.76 · 2025: $526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $287.92 | 2021 | |
| Gilead Sciences, INC. | $270.50 | 2025 | Biktarvy |
| Janssen Products, LP | $198.95 | 2021 | |
| Viiv Healthcare Company | $138.63 | 2021-2025 | Cabenuva |
| E.R. Squibb & Sons, L.L.C. | $94.50 | 2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $83.11 | 2021-2022 | |
| Insmed, INC. | $26.61 | 2025 | Arikayce |
| Shionogi INC | $22.45 | 2025 | Fetroja |
| Merck Sharp & Dohme LLC | $14.65 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Pitcock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.